Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 136th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
PBYI	PUMA BIOTECHNOLOGY INC	$9.78	-0.41%	-0.41%	7.35%	19.41%	59.54%	93.66%	271.86%	39.12%	-85.20%	$9.98	$4.58	2.00%	113.77%	0.97	221,000	-10.16%
PGEN	PRECIGEN INC	$8.05	3.07%	2.03%	16.16%	35.98%	147.69%	121.76%	466.90%	58.78%	-70.99%	$8.27	$2.99	2.66%	169.23%	1.79	4,134,000	18.42%
ONC	BEONE MEDICINES LTD	$365.27	-0.47%	-0.76%	1.58%	25.96%	28.58%	9.75%	103.07%	1.03%	1,129.04%	$385.22	$253.95	5.18%	43.84%	0.98	372,000	5.98%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$39.29	-1.80%	-5.39%	-0.23%	11.18%	46.06%	42.15%	19.90%	5.03%	N/A	$43.49	$25.52	9.66%	53.96%	0.81	784,000	-10.30%
ICCC	IMMUCELL CORP	$9.94	0.61%	-0.50%	1.53%	0.30%	54.59%	60.84%	86.14%	5.52%	25.35%	$12.10	$4.52	17.85%	119.91%	0.22	2,900	-35.56%
FENC	FENNEC PHARMACEUTICALS INC	$10.80	-1.37%	-1.91%	-12.55%	-2.09%	87.18%	18.81%	43.81%	16.38%	424.27%	$13.25	$5.65	18.49%	91.15%	0.71	118,000	-43.81%
CORT	CORCEPT THERAPEUTICS INC	$114.74	-0.77%	-2.35%	1.23%	30.55%	201.00%	36.76%	321.14%	475.72%	1,721.27%	$126.38	$28.66	9.21%	300.35%	1.01	963,000	-16.62%
HALO	HALOZYME THERAPEUTICS INC	$111.56	-1.18%	-3.10%	4.76%	44.55%	79.56%	52.22%	192.04%	181.36%	837.48%	$116.85	$61.23	4.52%	82.21%	0.76	2,574,000	15.06%
VCYT	VERACYTE INC	$46.08	1.88%	6.27%	6.69%	-23.44%	51.38%	37.10%	106.36%	1.86%	519.35%	$60.91	$29.46	24.35%	56.44%	1.89	1,570,000	-7.48%
REGN	REGENERON PHARMACEUTICALS INC	$750.51	-0.23%	-6.64%	-6.08%	18.79%	0.16%	33.84%	-8.80%	23.70%	84.69%	$859.34	$541.00	12.66%	38.73%	0.59	800,000	-30.43%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$26.75	-2.12%	-3.71%	11.60%	-0.04%	25.41%	43.66%	403.77%	18.36%	N/A	$31.77	$18.79	15.80%	42.36%	1.21	2,568,000	-16.24%
PTCT	PTC THERAPEUTICS INC	$64.96	-1.50%	-1.52%	-6.59%	-20.36%	-1.04%	7.11%	189.87%	75.33%	461.94%	$90.86	$60.80	28.51%	6.85%	0.98	899,000	-53.03%
JAZZ	JAZZ PHARMACEUTICALS PLC	$232.35	-2.49%	-3.42%	-7.31%	-2.26%	26.86%	80.09%	79.50%	76.52%	88.89%	$266.38	$128.80	12.77%	80.40%	0.69	777,000	-1.40%
PTGX	PROTAGONIST THERAPEUTICS INC	$140.97	-1.03%	-2.83%	-4.59%	15.90%	41.15%	116.41%	745.14%	702.33%	579.05%	$160.81	$62.24	12.34%	126.49%	0.93	508,000	-45.08%
RPRX	ROYALTY PHARMA PLC	$58.22	-0.26%	-0.51%	-5.19%	1.98%	25.56%	65.16%	114.52%	58.72%	N/A	$64.38	$35.23	9.57%	65.26%	0.45	2,843,000	52.60%
AUPH	AURINIA PHARMACEUTICALS INC	$16.42	-0.61%	-1.50%	1.92%	-2.20%	17.45%	48.46%	111.33%	-28.58%	521.97%	$19.25	$10.92	14.70%	50.44%	1.11	735,000	17.41%
VCEL	VERICEL CORP	$40.61	0.92%	0.97%	1.78%	-9.90%	32.93%	27.74%	21.15%	-15.75%	1,324.91%	$49.32	$28.95	17.66%	40.28%	1.43	527,000	-18.04%
ZVRA	ZEVRA THERAPEUTICS INC	$11.34	0.35%	-2.07%	-3.41%	-19.06%	29.16%	18.87%	135.27%	23.93%	-84.18%	$15.04	$8.01	24.58%	41.57%	0.89	1,341,000	80.73%
EXEL	EXELIXIS INC	$58.65	0.48%	0.86%	7.34%	8.05%	39.81%	44.56%	168.42%	184.29%	377.61%	$59.72	$33.76	1.79%	73.75%	0.60	2,236,000	74.82%
BCRX	BIOCRYST PHARMACEUTICALS INC	$8.27	-2.36%	-5.81%	-14.74%	-13.40%	-12.49%	9.54%	16.81%	-42.49%	85.84%	$11.22	$6.00	26.29%	37.83%	1.07	5,006,000	14.95%
BMRN	BIOMARIN PHARMACEUTICAL INC	$59.87	0.69%	-5.52%	-8.22%	3.81%	9.27%	10.83%	-32.33%	-22.03%	-35.47%	$70.98	$49.26	15.65%	21.54%	0.70	1,807,000	-23.37%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$75.73	-0.49%	-2.91%	-3.69%	21.34%	65.71%	95.33%	335.98%	564.88%	N/A	$82.94	$35.20	8.69%	115.14%	0.80	286,000	-61.04%
OMER	OMEROS CORP	$19.25	-0.93%	-8.55%	2.45%	94.25%	96.23%	360.53%	559.25%	43.66%	71.57%	$21.24	$4.06	9.37%	374.72%	1.56	841,000	-18.03%
ORMP	ORAMED PHARMACEUTICALS INC	$4.69	-1.26%	-1.26%	-6.57%	1.08%	42.99%	73.70%	79.69%	-79.01%	-35.75%	$5.47	$2.09	14.26%	124.40%	1.16	171,000	55.45%
XERS	XERIS BIOPHARMA HOLDINGS INC	$9.98	1.53%	14.32%	18.25%	28.94%	78.21%	23.51%	436.56%	321.10%	N/A	$11.33	$5.25	11.92%	90.10%	1.23	19,315,000	332.78%
INCY	INCYTE CORP	$123.20	-1.30%	-2.94%	-0.02%	7.45%	36.39%	46.86%	113.26%	79.41%	33.49%	$132.58	$82.82	7.07%	48.77%	0.53	1,712,000	19.22%
FTRE	FORTREA HOLDINGS INC	$19.74	-1.60%	-3.38%	7.46%	12.67%	122.55%	135.00%	-30.95%	N/A	N/A	$21.39	$8.39	7.71%	135.28%	1.69	1,171,000	-27.94%
RLYB	RALLYBIO CORP	$17.22	1.00%	1.77%	2.56%	7.22%	114.18%	286.45%	-36.13%	-86.55%	N/A	$17.57	$3.67	2.01%	369.21%	1.12	16,700	4.38%
CYPH	CYPHERPUNK TECHNOLOGIES INC	$3.23	-2.42%	-13.40%	76.99%	408.66%	416.80%	797.22%	134.06%	-90.64%	N/A	$4.19	$0.39	22.91%	721.88%	1.81	13,317,000	-50.23%
PLX	PROTALIX BIOTHERAPEUTICS INC	$2.69	0.00%	-2.18%	4.67%	14.47%	28.71%	24.54%	62.05%	96.35%	-53.61%	$3.19	$1.60	15.67%	68.13%	0.67	899,000	8.05%
ANAB	ANAPTYSBIO INC	$50.37	-0.85%	-6.58%	-11.68%	-23.65%	-9.06%	116.46%	180.46%	89.86%	N/A	$73.30	$29.48	31.28%	70.86%	0.89	678,000	64.16%
APMD	APNIMED INC	$23.90	10.29%	-6.31%	-8.95%	N/A	N/A	N/A	N/A	N/A	N/A	$35.29	$16.12	32.28%	48.26%	0.95	669,000	135.56%
ARGX	ARGENX SE	$970.66	-0.16%	0.71%	-5.91%	6.38%	37.82%	34.99%	97.44%	229.04%	N/A	$1.07k	$661.85	9.52%	46.66%	0.61	311,000	17.36%
ACAD	ACADIA PHARMACEUTICALS INC	$20.22	-1.51%	-23.44%	-30.06%	-19.76%	-4.03%	-5.16%	-2.98%	19.22%	-38.17%	$30.96	$19.69	34.69%	2.69%	0.98	2,513,000	-28.67%
MGTX	MEIRAGTX HOLDINGS PLC	$11.13	0.18%	-9.88%	-19.41%	-11.24%	37.58%	34.91%	126.68%	-13.39%	N/A	$15.35	$6.62	27.49%	68.13%	1.27	875,000	-5.91%
ASND	ASCENDIS PHARMA A	$228.07	-0.86%	-4.00%	-13.29%	-13.51%	4.45%	19.03%	143.56%	45.27%	1,022.94%	$282.15	$186.05	19.17%	22.58%	0.73	742,000	-0.80%
IOVA	IOVANCE BIOTHERAPEUTICS INC	$14.45	31.48%	35.81%	76.87%	243.23%	335.24%	547.98%	217.58%	-39.26%	83.61%	$15.30	$1.76	5.56%	721.02%	1.48	77,402,000	532.73%
HOWL	WEREWOLF THERAPEUTICS INC	$0.91	-2.15%	-7.33%	-3.29%	195.45%	14.18%	-58.45%	-57.48%	-94.81%	N/A	$2.15	$0.27	57.67%	237.04%	1.53	970,000	38.37%
OABI	OMNIAB INC	$4.74	0.00%	-3.66%	8.22%	84.44%	203.85%	194.41%	-8.67%	-53.30%	N/A	$5.43	$1.30	12.71%	264.62%	0.77	1,280,000	89.63%
INSM	INSMED INC	$115.63	-1.73%	-4.30%	-5.08%	10.40%	-24.58%	-18.37%	357.94%	340.83%	729.48%	$212.75	$90.39	45.65%	27.92%	0.98	1,668,000	-4.36%
RIGL	RIGEL PHARMACEUTICALS INC	$48.89	-0.95%	0.14%	5.87%	25.23%	90.09%	70.05%	352.69%	34.68%	36.95%	$52.24	$24.95	6.41%	95.95%	1.27	182,000	0.55%
GMAB	GENMAB A	$35.57	0.59%	0.99%	7.27%	36.70%	37.71%	21.28%	0.85%	-15.99%	111.75%	$35.70	$23.62	0.36%	50.59%	0.71	3,828,000	36.96%
PRLD	PRELUDE THERAPEUTICS INC	$3.96	1.28%	-18.35%	-29.29%	-19.68%	28.99%	189.05%	28.16%	-87.18%	N/A	$6.83	$1.15	42.02%	244.35%	1.55	458,000	-7.66%
VRTX	VERTEX PHARMACEUTICALS INC	$526.73	-0.18%	2.28%	-3.27%	5.42%	18.86%	33.24%	51.47%	189.06%	519.68%	$560.25	$392.50	5.98%	34.20%	0.57	655,000	-20.61%
SLN	SILENCE THERAPEUTICS PLC	$10.80	-3.57%	-12.12%	-20.18%	0.09%	116.87%	90.48%	9.98%	-47.60%	N/A	$17.58	$4.19	38.55%	157.76%	0.76	885,000	24.47%
LEGN	LEGEND BIOTECH CORP	$18.82	1.07%	0.97%	-9.43%	-35.96%	8.72%	-42.71%	-71.98%	-60.14%	N/A	$37.46	$16.24	49.75%	15.89%	0.75	1,974,000	15.10%
VIR	VIR BIOTECHNOLOGY INC	$10.65	1.33%	-7.39%	-2.65%	2.60%	25.89%	89.17%	13.66%	-75.32%	N/A	$11.94	$4.82	10.80%	121.18%	1.37	1,523,000	11.17%
ADMA	ADMA BIOLOGICS INC	$9.96	-1.58%	1.53%	6.07%	19.00%	8.85%	-32.24%	178.21%	781.42%	36.07%	$20.46	$7.21	51.31%	38.14%	1.18	3,458,000	-3.08%
ANL	ADLAI NORTYE GROUP LTD	$15.65	1.62%	-5.72%	10.29%	37.16%	136.76%	784.18%	4.33%	N/A	N/A	$17.25	$0.88	9.28%	1,680.43%	0.89	63,000	-0.79%
SEPN	SEPTERNA INC	$39.13	-1.53%	-3.10%	2.57%	12.60%	67.94%	115.59%	N/A	N/A	N/A	$51.10	$17.55	23.42%	122.96%	1.30	551,000	63.02%
ARMP	ARMATA PHARMACEUTICALS INC	$3.59	-5.03%	-14.52%	-34.85%	-44.43%	-58.21%	21.69%	19.67%	-0.83%	-98.14%	$16.34	$2.94	78.03%	22.11%	0.41	92,000	6.98%
ARVN	ARVINAS INC	$7.50	-0.13%	-11.87%	-18.48%	-9.53%	-26.33%	-12.08%	-61.81%	-90.92%	N/A	$14.51	$6.97	48.31%	7.60%	1.40	496,000	-3.13%
MDGL	MADRIGAL PHARMACEUTICALS INC	$509.44	-1.47%	-1.81%	-5.66%	-3.38%	0.81%	14.97%	248.84%	536.56%	4,051.92%	$615.00	$393.61	17.16%	29.43%	0.77	214,000	-35.93%
FHTX	FOGHORN THERAPEUTICS INC	$3.52	0.00%	-16.98%	-38.68%	-27.57%	-20.36%	-29.74%	-29.60%	-73.91%	N/A	$7.61	$3.27	53.75%	7.65%	1.59	376,000	11.57%
NRXS	NEURAXIS INC	$7.76	4.86%	6.16%	29.12%	8.68%	17.40%	149.52%	104.21%	N/A	N/A	$9.33	$2.21	16.83%	251.13%	1.09	103,000	60.94%
SRZN	SURROZEN INC	$31.98	7.89%	81.70%	45.23%	24.34%	16.50%	174.27%	335.10%	-69.84%	N/A	$37.83	$11.39	15.46%	180.77%	0.73	558,000	36.10%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$7.65	0.26%	2.55%	0.13%	19.72%	165.63%	170.32%	-23.50%	-84.20%	N/A	$9.42	$2.55	18.79%	200.59%	1.10	1,745,000	-10.14%
ALNY	ALNYLAM PHARMACEUTICALS INC	$254.07	-0.51%	0.96%	5.56%	-13.44%	-19.62%	-43.22%	43.46%	43.18%	263.27%	$495.55	$197.81	48.73%	28.44%	0.86	754,000	-34.32%
URGN	UROGEN PHARMA LTD	$40.45	-1.10%	-5.40%	-6.13%	12.14%	137.94%	111.34%	188.72%	137.80%	N/A	$50.81	$15.86	20.39%	155.04%	0.94	638,000	-45.28%
FBIO	FORTRESS BIOTECH INC	$2.20	1.38%	-10.20%	-19.56%	-25.42%	-18.52%	-43.59%	-49.48%	-95.93%	-94.85%	$4.53	$2.14	51.43%	2.80%	1.13	257,000	-2.28%
TVTX	TRAVERE THERAPEUTICS INC	$59.99	-2.57%	-0.48%	-9.49%	2.90%	116.88%	149.54%	571.03%	150.06%	174.18%	$68.73	$22.59	12.72%	165.56%	1.17	1,547,000	25.26%
TARS	TARSUS PHARMACEUTICALS INC	$76.69	-0.16%	-0.51%	3.30%	25.19%	14.60%	32.04%	331.57%	256.53%	N/A	$91.53	$53.89	16.21%	42.31%	0.87	363,000	-72.29%
KRYS	KRYSTAL BIOTECH INC	$335.06	-0.60%	-4.51%	-6.76%	-11.39%	35.68%	89.57%	188.84%	523.25%	N/A	$382.54	$175.85	12.41%	90.54%	1.28	226,000	-24.41%
HYPD	HYPERION DEFI INC	$3.99	1.92%	0.00%	16.67%	25.47%	24.69%	-61.04%	-97.00%	-98.98%	N/A	$11.89	$2.34	66.44%	70.51%	1.38	360,000	-51.61%
NVO	NOVO NORDISK A S	$38.31	-1.03%	-2.77%	-15.49%	-20.75%	8.56%	-30.97%	-57.87%	-20.27%	83.30%	$64.16	$35.13	40.29%	9.07%	0.67	9,402,000	-17.74%
AVXL	ANAVEX LIFE SCIENCES CORP	$2.36	0.43%	-4.45%	-15.71%	-9.23%	-16.31%	-72.72%	-63.97%	-86.76%	-37.07%	$10.38	$2.26	77.26%	4.66%	1.75	1,756,000	236.40%
KYMR	KYMERA THERAPEUTICS INC	$110.51	-1.33%	-9.46%	-6.99%	1.09%	39.04%	88.91%	695.04%	89.07%	N/A	$130.05	$54.09	15.02%	104.31%	1.64	447,000	-38.26%
IMCR	IMMUNOCORE HOLDINGS PLC	$30.85	0.69%	-4.84%	-15.06%	1.41%	5.33%	-10.16%	-40.56%	-16.62%	N/A	$40.72	$27.56	24.23%	11.96%	0.79	344,000	28.84%
NAGE	NIAGEN BIOSCIENCE INC	$2.95	-1.01%	-4.53%	-5.75%	-10.61%	-31.07%	-70.20%	102.05%	-51.24%	0.34%	$9.28	$2.87	68.21%	2.79%	1.52	279,000	-32.12%
ARDX	ARDELYX INC	$3.39	-0.59%	-6.35%	-10.32%	-35.18%	-38.92%	-39.79%	-16.91%	164.84%	-72.94%	$8.40	$3.31	59.64%	2.42%	1.18	4,370,000	31.71%
YARW	YARROW BIOSCIENCE INC	$24.19	0.79%	-15.66%	-26.61%	-25.28%	-17.72%	47.05%	-88.02%	-98.07%	N/A	$46.95	$16.00	48.48%	51.19%	1.03	101,000	-6.48%
INDP	INDAPTUS THERAPEUTICS INC	$2.85	-13.37%	-28.57%	148.91%	-6.86%	60.11%	-4.68%	-96.31%	-98.80%	-99.98%	$5.96	$0.92	52.18%	209.78%	1.12	589,000	0.86%
MGNX	MACROGENICS INC	$3.77	-7.14%	-8.50%	-5.51%	-22.43%	36.59%	115.43%	-19.10%	-81.60%	-87.19%	$5.08	$1.29	25.79%	192.25%	1.49	616,000	-67.80%
XNCR	XENCOR INC	$25.00	-2.34%	-0.64%	-8.31%	60.26%	120.26%	116.45%	24.07%	-22.24%	2.54%	$30.61	$10.38	18.33%	140.96%	1.18	1,621,000	5.81%
RYTM	RHYTHM PHARMACEUTICALS INC	$95.71	-2.89%	-3.59%	-9.82%	-13.02%	23.90%	-4.90%	317.49%	625.63%	N/A	$122.20	$74.51	21.68%	28.45%	1.16	811,000	-9.59%
MRNA	MODERNA INC	$203.46	3.13%	11.45%	44.98%	191.91%	321.85%	703.24%	96.98%	-46.30%	N/A	$208.90	$22.28	2.61%	813.20%	1.40	13,278,000	-0.61%
RGNX	REGENXBIO INC	$7.45	-0.27%	-8.59%	-21.58%	-37.02%	-4.12%	-24.37%	-54.74%	-82.30%	-46.33%	$16.19	$5.46	53.98%	36.45%	1.52	2,096,000	58.07%
IVA	INVENTIVA SA	$3.29	-6.80%	-9.86%	-29.70%	-7.32%	-39.96%	-43.95%	-21.67%	-77.15%	N/A	$7.98	$3.11	58.78%	5.96%	0.36	3,832,000	9.99%
ELOX	ELOXX PHARMACEUTICALS INC	$15.42	2.80%	-7.83%	-8.05%	29.25%	637.80%	1,541,900.00%	-70.86%	-97.82%	-99.03%	$23.40	$0.00	34.10%	1,541,900.00%	-107.26	6,100	-62.80%
LKFT	LAKEFRONT BIOTHERAPEUTICS NV	$29.52	-1.07%	-2.22%	3.58%	-0.51%	2.36%	-14.26%	-14.56%	-43.42%	-53.36%	$37.78	$25.68	21.86%	14.95%	0.60	199,000	-3.86%
ACIU	AC IMMUNE SA	$2.60	-0.38%	-4.76%	-1.52%	-2.26%	1.56%	-14.47%	-8.77%	-61.99%	-85.18%	$4.00	$2.10	35.00%	24.11%	1.12	139,000	-26.46%
RANI	RANI THERAPEUTICS HOLDINGS INC	$0.80	3.09%	2.83%	-6.32%	4.58%	4.85%	63.27%	-63.22%	-95.41%	N/A	$3.87	$0.45	79.33%	79.78%	1.38	406,000	-35.04%
STTK	SHATTUCK LABS INC	$6.54	1.71%	0.62%	-6.70%	-4.53%	9.73%	188.11%	330.26%	-65.58%	N/A	$8.33	$1.70	21.49%	284.71%	1.43	957,000	-2.05%
IFRX	INFLARX NV	$145.00	7,867.03%	6,871.15%	6,707.51%	6,259.65%	17,327.88%	10,483.94%	4,765.77%	5,520.16%	N/A	$145.00	$0.80	0.00%	18,070.43%	-0.33	0	-100.00%
SRPT	SAREPTA THERAPEUTICS INC	$18.64	-0.85%	-10.43%	-11.36%	9.52%	-8.98%	-0.96%	-84.62%	-79.00%	-69.43%	$25.32	$14.69	26.38%	26.89%	1.09	1,368,000	-39.68%
CCCC	C4 THERAPEUTICS INC	$3.13	0.48%	-5.44%	-15.63%	-28.05%	33.19%	40.36%	68.28%	-93.48%	N/A	$5.17	$1.69	39.46%	85.21%	2.03	1,554,000	-44.08%
AXSM	AXSOME THERAPEUTICS INC	$186.14	-4.00%	-8.35%	-6.24%	-22.80%	15.98%	58.26%	166.33%	444.75%	2,320.55%	$260.19	$117.30	28.46%	58.69%	0.88	1,578,000	123.20%
ZYME	ZYMEWORKS INC	$27.20	0.29%	-1.32%	-7.51%	12.86%	12.35%	57.86%	329.02%	-0.55%	N/A	$31.34	$16.00	13.21%	69.97%	0.93	684,000	-50.29%
ASMB	ASSEMBLY BIOSCIENCES INC	$23.48	-0.55%	-7.74%	-30.18%	-12.91%	-11.86%	-4.67%	121.09%	-43.77%	-72.90%	$39.71	$21.80	40.86%	7.73%	0.99	230,000	94.92%
PYPD	POLYPID LTD	$5.29	-0.38%	-2.94%	2.92%	6.44%	25.65%	58.86%	17.29%	-97.77%	N/A	$5.73	$3.06	7.68%	72.88%	0.76	66,000	-13.16%
ALGS	ALIGOS THERAPEUTICS INC	$5.62	1.44%	-1.06%	-4.10%	3.50%	-14.33%	-41.58%	-69.91%	-98.52%	N/A	$13.69	$3.98	58.95%	41.21%	1.46	11,500	-85.53%
XFOR	X4 PHARMACEUTICALS INC	$2.90	-3.81%	-15.45%	-28.22%	-31.44%	-27.32%	-13.43%	-91.13%	-98.14%	N/A	$4.83	$2.80	39.96%	3.57%	1.34	1,706,000	103.58%
UTHR	UNITED THERAPEUTICS CORP	$481.47	-0.84%	-3.24%	-5.66%	-11.64%	-18.17%	13.47%	113.16%	159.55%	318.60%	$609.35	$409.07	20.99%	17.70%	0.40	415,000	-33.92%
INVA	INNOVIVA INC	$21.11	-0.57%	0.62%	1.64%	-8.77%	-7.86%	10.93%	62.51%	22.45%	94.74%	$25.15	$16.52	16.05%	27.78%	0.37	556,000	-34.97%
SCTX	SCRIBE THERAPEUTICS INC	$23.03	5.79%	-17.96%	-24.59%	N/A	N/A	N/A	N/A	N/A	N/A	$39.60	$17.31	41.84%	33.08%	-0.62	671,000	118.57%
EDIT	EDITAS MEDICINE INC	$2.59	3.19%	-11.30%	-15.36%	-19.06%	16.14%	-26.42%	-66.79%	-93.91%	-80.87%	$4.54	$1.66	42.91%	56.02%	2.11	1,568,000	-28.86%
CMMB	CHEMOMAB THERAPEUTICS LTD	$1.61	-1.83%	-32.35%	-40.81%	-0.62%	8.78%	-39.25%	-55.03%	-96.42%	N/A	$3.58	$1.35	55.03%	19.26%	1.08	438,000	25.14%
KURA	KURA ONCOLOGY INC	$10.81	1.84%	-7.89%	-14.58%	-1.50%	39.78%	20.46%	18.48%	-42.28%	75.41%	$13.90	$7.36	22.27%	46.87%	1.10	1,890,000	14.82%
CRSP	CRISPR THERAPEUTICS AG	$56.00	3.53%	-5.13%	-1.72%	-0.62%	26.30%	-12.18%	23.38%	-49.18%	N/A	$78.48	$44.12	28.64%	26.93%	1.58	1,575,000	23.92%
RARE	ULTRAGENYX PHARMACEUTICAL INC	$15.32	6.32%	-1.89%	-39.23%	-50.07%	-20.62%	-49.54%	-57.03%	-82.21%	-77.66%	$39.89	$12.73	61.59%	20.35%	1.08	5,855,000	18.52%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: B, Growth: C, Momentum: A, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 24 points higher than the biotech industry average of 24.

PBYI passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 93.66% over the past year, overperforming other biotech stocks by 167 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -38.65% from Puma Biotechnology's current stock price of $9.78.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Precigen (NASDAQ:PGEN)

Precigen (NASDAQ:PGEN) is the #2 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Precigen (NASDAQ:PGEN) is: Value: C, Growth: A, Momentum: A, Sentiment: B, Safety: F, Financials: C, and AI: B.

Precigen (NASDAQ:PGEN) has a Due Diligence Score of 29, which is 5 points higher than the biotech industry average of 24.

PGEN passed 10 out of 33 due diligence checks and has average fundamentals. Precigen has seen its stock return 121.76% over the past year, overperforming other biotech stocks by 195 percentage points.

Precigen has an average 1 year price target of $13.67, an upside of 69.78% from Precigen's current stock price of $8.05.

Precigen stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Precigen, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Beone Medicines (NASDAQ:ONC)

Beone Medicines (NASDAQ:ONC) is the #3 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 28, which is 4 points higher than the biotech industry average of 24.

ONC passed 9 out of 33 due diligence checks and has average fundamentals. Beone Medicines has seen its stock return 9.75% over the past year, overperforming other biotech stocks by 83 percentage points.

Beone Medicines has an average 1 year price target of $418.55, an upside of 14.59% from Beone Medicines's current stock price of $365.27.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Beone Medicines, 81.82% have issued a Strong Buy rating, 18.18% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.33%, which is 3 percentage points higher than the biotech industry average of 2.12%.

Oramed Pharmaceuticals's dividend payout ratio of 5.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.84%, which is 3 percentage points higher than the biotech industry average of 2.12%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 46.1% indicates that its high dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.59%, which is -1 percentage points lower than the biotech industry average of 2.12%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 48.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.59% in the last day, and down -3.09% over the last week. Stablecoin Development was the among the top gainers in the biotechnology industry, gaining 108.28% yesterday.

Stablecoin Development shares are trading lower. The company announced it is aware of unusual trading activity and that there has been no material development in its business and affairs.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 42.15% in the past year. It has overperformed other stocks in the biotech industry by 115 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 80.09% in the past year. It has overperformed other stocks in the biotech industry by 153 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 44.56% in the past year. It has overperformed other stocks in the biotech industry by 118 percentage points.

Are biotech stocks a good buy now?

64.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 63.92% over the next year.

3.04% of biotech stocks have a Zen Rating of A (Strong Buy), 3.69% of biotech stocks are rated B (Buy), 44.9% are rated C (Hold), 36.88% are rated D (Sell), and 11.5% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 9.98x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Precigen (NASDAQ:PGEN)

3. Beone Medicines (NASDAQ:ONC)

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Precigen (NASDAQ:PGEN)

3. Beone Medicines (NASDAQ:ONC)

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.